The Ministry of Trade, Agribusiness and Industry has secured a €415,437.78 grant to support the implementation of the PharmaVax Programme, a strategic initiative aimed at transforming Ghana’s pharmaceutical industry and positioning the country as a leading manufacturing hub in West Africa.
The programme, being implemented in collaboration with the European Union, GIZ Ghana and other development partners, is expected to strengthen governance in the pharmaceutical sector, attract investment, expand exports and improve the competitiveness of local drug manufacturers.
Speaking at a stakeholders’ meeting in Accra on Thursday, Director of Administration at the Ministry, Mr Yaw Sakyi, who represented the Minister for Trade, Agribusiness and Industry, Hon. Elizabeth Ofosu-Adjare, said government remained committed to building a resilient pharmaceutical industry capable of meeting domestic demand while competing effectively in regional markets.
He noted that the country’s pharmaceutical policy would provide the institutional and regulatory framework needed to drive sustained growth in the sector and support Ghana’s ambition of becoming the pharmaceutical manufacturing hub of the sub-region.
Mr Sakyi expressed appreciation to the European Union and the German Federal Ministry for Economic Cooperation and Development for providing the €415,437.78 grant to support the implementation of the programme.
According to the Ministry, the PharmaVax Programme is built on four strategic pillars: strengthening governance institutions within the pharmaceutical sector, enhancing public-private dialogue, improving the environment for foreign direct investment and trade, and promoting greater transparency in investment and regulatory approval processes.
Head of the Pharmaceutical Manufacturing Development Unit at the Ministry, Mr Godfred Gobah, said the programme would also intensify engagement with private sector players while increasing Ghana’s participation in local and international trade events to showcase the country’s pharmaceutical manufacturing potential.
He explained that creating greater visibility for Ghana’s pharmaceutical industry would help attract new investments and open additional export opportunities for locally manufactured medicines.
The Ministry expects the initiative to contribute significantly to its long-term industrialisation agenda by achieving several key targets by 2030.
Among the objectives are doubling the value of pharmaceutical exports within the ECOWAS market and increasing the share of locally manufactured pharmaceutical products in the domestic market from the current 30 per cent to 60 per cent.
Officials believe the programme will strengthen Ghana’s pharmaceutical value chain, reduce dependence on imported medicines, create skilled employment and improve the country’s capacity to supply quality pharmaceutical products across the West African sub-region.
The PharmaVax Programme forms part of broader government efforts to promote industrialisation, strengthen local manufacturing and position Ghana as a competitive destination for investment in high-value industries.




